Latest Revvity News & Updates

See the latest news and media coverage for Revvity. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Revvity

Health science technologies and services company

revvity.com
Headquarters
Waltham, United States
Founded year
2023
Company type
Public company
Number of employees
10,000+

Last updated

Latest news about Revvity

In short: Revvity exceeded Q1 2026 earnings expectations, reporting 7% revenue growth, and announced plans to divest its China immunodiagnostics business.

Company announcements

  • Revvity

    Revvity launches Signals BioDesign™

    The cloud-native solution streamlines biologics research workflows and enhances R&D collaboration.

  • Revvity

    Revvity announces Q1 2026 financial results

    Reports $711M revenue, 7% growth, adjusted EPS $1.06. Intends to divest China Immunodiagnostics business. Updates 2026 guidance to $2.81-2.84B revenue.

  • Revvity

    Revvity will present at investor conferences

    Presentations include BofA Health Care (May 13) and Goldman Sachs Global Healthcare (June 9). Live webcasts and 30-day replays will be available.

  • Revvity

    Revvity unveils Signals BioDesign offering

    It streamlines molecular cloning workflows for biotech and pharma R&D, enabling high-throughput construct design up to 1,000 with real-time collaboration and Signals One integration.

Unlock all announcements with a

Media coverage

  • The Globe and Mail

    Revvity Earnings Call: Margin Beat, Portfolio Reset

    Revvity's latest earnings call struck an upbeat tone as management highlighted better-than-expected Q1 results and rising margins despite pockets of weakness. Executives framed the planned...

  • GuruFocus

    Q1 2026 Revvity Inc Earnings Call Transcript

    May 05, 2026 / 11:30AM GMTOperator Ladies and gentlemen, thank you for joining us, and welcome to the Q1 2026 Revvity earnings conference call. (Operator...

  • The Globe and Mail

    Revvity (NYSE:RVTY) Surprises With Q1 CY2026 Sales

    Formerly known as PerkinElmer until its rebranding in 2023, Revvity (NYSE:RVTY) provides health science technologies and services that support the complete workflow from discovery to...

  • GenomeWeb

    Revvity to Divest China Immunodiagnostics Business as Q1 Earnings Beat...

    Revvity said on Tuesday that it plans to divest its immunodiagnostics business in China. The company said that it has entered into a letter of...

Unlock all articles with a

Never miss news about Revvity

Track Revvity and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Revvity competitors & trending companies

Browse news for competitors to Revvity and other trending companies.